About this Research Topic
In this Research Topic, we will focus on factors that are known to influence the development of MS, with emphasis on those susceptible to preventive interventions. These will include non-infectious environmental factors (e.g., correction of vitamin D deficiency, smoking cessation, and diet modifications), infectious environmental factors (e.g., development of EBV vaccines and anti-herpesvirus drugs, antiviral medications targeting human endogenous retroviruses, and therapeutic use of helminth-derived molecules), as well as the identification of high-risk individuals that should be given priority in the implementation of preventive strategies (e.g., first degree relatives of people with MS).
For this Research Topic we welcome submissions of:
• Original Research
• Brief Research Report
• Systematic Review
• Policy and Practice Reviews
• Hypothesis and Theory
• Clinical Trials
Topic Editor Bruno Gran received financial support from Biogen Idec, Merck, Bayer Healthcare, Teva UK, Novartis, and Genzyme. Topic Editor Radu Tanasescu received financial support from Sanofi Genzyme. The other Topic Editors declare no competing interests with regard to the Research Topic subject.
Keywords: multiple sclerosis prevention, genetics, environmental factors, vaccine
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.